BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26683645)

  • 21. Cryopyrin-associated periodic syndrome (CAPS) in a patient with NLRP3 T348M mutation.
    Kreft B; Schlinsog AS; Wohlrab J
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1266-1268. PubMed ID: 30184330
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurologic manifestations of the cryopyrin-associated periodic syndrome.
    Kitley JL; Lachmann HJ; Pinto A; Ginsberg L
    Neurology; 2010 Apr; 74(16):1267-70. PubMed ID: 20404307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urticaria, fever, and hypofibrinogenemia.
    Mohr V; Schulz A; Lohse P; Schumann C; Debatin KM; Schuetz C
    Arthritis Rheumatol; 2014 May; 66(5):1377. PubMed ID: 24782193
    [No Abstract]   [Full Text] [Related]  

  • 24. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
    Idorn L; Vissing NH; Jensen L; Herlin T
    Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Update in interleukin-1 inhibition].
    de Boysson H
    Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
    [No Abstract]   [Full Text] [Related]  

  • 26. A Case of Amyloidosis Caused by Sporadic Muckle-Wells Syndrome: Response to Treatment With Anakinra.
    İlgen U; Küçükşahin O; Erdoğmuş Ş; Nergizoğlu G
    J Clin Rheumatol; 2018 Aug; 24(5):290-291. PubMed ID: 29239931
    [No Abstract]   [Full Text] [Related]  

  • 27. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
    Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
    Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryopyrin-associated periodic syndrome.
    Posch C; Kaulfersch W; Rappersberger K
    Pediatr Dermatol; 2014; 31(2):228-31. PubMed ID: 22891689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryopyrin-associated periodic syndrome.
    Giat E; Lidar M
    Isr Med Assoc J; 2014 Oct; 16(10):659-61. PubMed ID: 25438464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CINCA syndrome in an infant presenting with hydrocephalus.
    Turel O; Goknar N; Uzuner S; Kasapcopur O; Cuisset L
    Int J Rheum Dis; 2014 Mar; 17(3):346-8. PubMed ID: 24618115
    [No Abstract]   [Full Text] [Related]  

  • 31. Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes.
    Cantarini L; Lucherini OM; Frediani B; Brizi MG; Bartolomei B; Cimaz R; Galeazzi M; Rigante D
    Int J Immunopathol Pharmacol; 2011; 24(4):827-36. PubMed ID: 22230390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 16-year-old male with recurrent inflammation and hearing loss.
    Reece JL; Lancaster JD; Nield LS
    Pediatr Ann; 2010 Dec; 39(12):753-6. PubMed ID: 21162483
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.
    Kullenberg T; Löfqvist M; Leinonen M; Goldbach-Mansky R; Olivecrona H
    Rheumatology (Oxford); 2016 Aug; 55(8):1499-506. PubMed ID: 27143789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome].
    Aróstegui JI
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():22-8. PubMed ID: 21596183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in moyamoya syndrome.
    Wohlrab F; Bauknecht C; Meisel C; Dreier JP
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):e1-3. PubMed ID: 33109682
    [No Abstract]   [Full Text] [Related]  

  • 36. Corneal response to canakinumab in cryopyrin associated periodic fever syndrome.
    Tsatsos M; Hawkin PN; Hossain P
    Br J Ophthalmol; 2013 Aug; 97(8):1081-2. PubMed ID: 23740963
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
    Yadlapati S; Efthimiou P
    Mod Rheumatol; 2016; 26(1):3-8. PubMed ID: 26140469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes.
    Bujan-Rivas S; Basagaña M; Sena F; Méndez M; Dordal MT; Gonzalez-Roca E; Ruiz-Ortiz E; Mensa-Vilaró A; Plaza S; Modesto C; Ordi-Ros J; Yagüe J; Martínez-Valle F; Aróstegui JI
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):27-31. PubMed ID: 28079503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome.
    Endo K; Suzuki A; Sato K; Shiga T
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25883259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muckle-Wells cryopyrinopathy: complex phenotyping and response to therapy in a new multiplex kindred.
    Headley AP; Cordingley F; Hawkins PN; Riminton DS
    Inflammation; 2014 Apr; 37(2):396-401. PubMed ID: 24150829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.